Quality of Vision and Quality of Life With LASIK
Patient Quality of Vision and Quality of Life With LASIK Surgery
1 other identifier
observational
49
1 country
1
Brief Summary
The investigators are administering a validated questionnaire looking at patient reported quality of life and quality of vision after LASIK surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 6, 2014
CompletedFirst Posted
Study publicly available on registry
June 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedMarch 19, 2024
March 1, 2024
8.9 years
June 6, 2014
March 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of Vision and Quality of Life Questionnaires after LASIK Surgery
Patients will complete questionnaires preoperatively and postoperatively at month twelve.
12 months
Study Arms (1)
Quality of Vision after LASIK surgery
Questionnaire
Interventions
Patient questionnaire
Eligibility Criteria
Adults over the age of 21 with healthy eyes and nearsightedness, farsightedness and/or astigmatism
You may qualify if:
- Are aged 21 years or older.
- Have the ability to give informed consent.
- Speak and read English fluently.
- Have not previously had any form of refractive surgery, including prior LASIK or cataract surgery.
- May benefit from increased spectacle independence.
- Have been determined to be a good candidate for the LASIK procedure based on the investigator's assessment of medical and ophthalmic health, general cognitive function, and physical and social limitations.
- Have a treatment target of bilateral emmetropia.
- Express willingness and potential ability to return for all follow-up examinations through the 12-month follow-up exam under the care of the treating investigator.
- Are not enrolled in any other research study.
You may not qualify if:
- Subjects under the age of 21.
- Patients with excessively thin corneas.
- Patients with topographic evidence of keratoconus.
- Patients with ectactic eye disorders.
- Patients with autoimmune diseases.
- Patients who are pregnant or nursing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Edward E. Manchelead
Study Sites (1)
Stanford Eye Laser Center
Palo Alto, California, 94303, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edward E Manche, MD
Stanford University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor of Ophthalmology
Study Record Dates
First Submitted
June 6, 2014
First Posted
June 11, 2014
Study Start
March 1, 2014
Primary Completion
February 1, 2023
Study Completion
February 1, 2023
Last Updated
March 19, 2024
Record last verified: 2024-03